Nanopublication

< Home

ID

http://purl.org/np/RA29A1XL8_FwRpUAbDdjhoL1b2I_tcnXRDStd3NBuWt0w

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix pav: <http://purl.org/pav/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RA29A1XL8_FwRpUAbDdjhoL1b2I_tcnXRDStd3NBuWt0w#> .
@prefix this: <http://purl.org/np/RA29A1XL8_FwRpUAbDdjhoL1b2I_tcnXRDStd3NBuWt0w> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://identifiers.org/hmdb/HMDB0303394> a biolink:ChemicalEntity;
    rdfs:label "Dextroamphetamine sulfate";
    biolink:category biolink:ChemicalEntity .
  
  <http://purl.obolibrary.org/obo/MONDO_0005302> a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "Attention Deficit Disorder with Hyperactivity";
    biolink:category biolink:DiseaseOrPhenotypicFeature .
  
  sub:_1 a biolink:Association;
    rdf:object <http://purl.obolibrary.org/obo/MONDO_0005302>;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/hmdb/HMDB0303394>;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-28T09:01:37.010437"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4727-9435;
    prov:wasQuotedFrom "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" .
  
  biolink: pav:version "2.3.0" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCTQs+mANCSHWhIW/YPio468UdGNHsPvADpjfaW8um/v2L4AoDIANginfoU65VNbPT5D0ADt1y0uFNne3VEMr9Y+I2HFaz6IKj+LdYMJk6VUf5WJoImRHIX6BZQwcUc22CbTBFYxvqvp3UmmHrCrhLIZjDSyutExK3tOTRoMDjGowIDAQAB";
    npx:hasSignature "PtuyKiasP0PHfxPxu8SFpH2OwHHta6EZFZr+U5d8keOJ2y/Q25cqdaOlkMzPQq8eS2CPa/6ce7c3YYgNUjKVO5WeofE3k0R6mmP2yqNVFhIHEZOE370XIBgtMQGRFqHZnW2MR+m1afqfqjEuPjbA+kAPrlZUYprRaUp/tVM4cwM=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-10-28T09:01:37.010437"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4727-9435 .
}